Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Novartis
NVS
$297B
| $20.7M | ﹤0.01% |
185,603
+20,161
| +12% | +$2.15M |
|
1627
Peabody Energy
BTU
$2.9B
| $20.6M | ﹤0.01% |
1,518,351
+118,307
| +8% | +$1.9M |
|
1628
Tidewater
TDW
$4.12B
| $20.6M | ﹤0.01% |
486,644
-4,149
| -0.8% | -$206K |
|
1629
Amdocs
DOX
$6.22B
| $20.5M | ﹤0.01% |
224,076
+10,766
| +5% | +$940K |
|
1630
Transmedics
TMDX
$2.91B
| $20.5M | ﹤0.01% |
304,367
+6,934
| +2% | +$477K |
|
1631
Teladoc Health
TDOC
$1.3B
| $20.5M | ﹤0.01% |
2,571,673
+127,960
| +5% | +$1.29M |
|
|
QXO
1632
QXO Inc
QXO
$17.4B
| $20.4M | ﹤0.01% |
1,506,186
-38,038
| -2% | -$517K |
|
1633
Teva Pharmaceuticals
TEVA
$41.2B
| $20.4M | ﹤0.01% |
1,324,936
+296,012
| +29% | +$5.29M |
|
1634
First Bancorp
FBNC
$2.68B
| $20.3M | ﹤0.01% |
506,609
-688
| -0.1% | -$29K |
|
|
TWO
1635
Two Harbors Investment
TWO
$1.27B
| $20.3M | ﹤0.01% |
1,521,548
-20,910
| -1% | -$271K |
|
|
FOLD
1636
DELISTED
Amicus Therapeutics
FOLD
| $20.3M | ﹤0.01% |
2,491,080
-95,723
| -4% | -$886K |
|
1637
First Busey Corp
BUSE
$2.58B
| $20.3M | ﹤0.01% |
937,591
+230,268
| +33% | +$5.35M |
|
1638
Coca-Cola Europacific Partners
CCEP
$47.9B
| $20.1M | ﹤0.01% |
231,420
-10,457
| -4% | -$853K |
|
1639
Twist Bioscience
TWST
$7.25B
| $20.1M | ﹤0.01% |
512,415
-30,417
| -6% | -$1.37M |
|
1640
Vericel Corp
VCEL
$2.31B
| $20.1M | ﹤0.01% |
449,615
-1,849
| -0.4% | -$99.5K |
|
1641
Pegasystems
PEGA
$5.38B
| $20M | ﹤0.01% |
576,316
-46,280
| -7% | -$2.05M |
|
1642
Ennis
EBF
$564M
| $20M | ﹤0.01% |
995,093
+725,379
| +269% | +$15.1M |
|
1643
Acadia Pharmaceuticals
ACAD
$5.03B
| $19.9M | ﹤0.01% |
1,200,839
-50,493
| -4% | -$917K |
|
1644
Tronox
TROX
$1.04B
| $19.9M | ﹤0.01% |
2,832,510
+375,643
| +15% | +$3.23M |
|
1645
Federal Agricultural Mortgage
AGM
$2.56B
| $19.9M | ﹤0.01% |
106,253
+4,963
| +5% | +$974K |
|
1646
CAE Inc. Common Shares
CAE
$8.74B
| $19.9M | ﹤0.01% |
807,985
-20,866
| -3% | -$508K |
|
1647
Braze
BRZE
$2.99B
| $19.9M | ﹤0.01% |
550,355
+12,409
| +2% | +$499K |
|
1648
Scholar Rock
SRRK
$6.44B
| $19.8M | ﹤0.01% |
617,107
-5,302
| -0.9% | -$204K |
|
1649
C3.ai
AI
$1.59B
| $19.5M | ﹤0.01% |
928,592
-4,547
| -0.5% | -$129K |
|
1650
Chemours
CC
$2.37B
| $19.5M | ﹤0.01% |
1,438,732
+136,460
| +10% | +$2.27M |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.